• Grading of recommendations, assessment, development, and evaluation (GRADE) : Moderna COVID-19 vaccine Cite CITE Title : Grading of recommendations, assessment, development, and evaluation (GRADE) : Moderna COVID-19 vaccine Personal Author(s) : Wallace, Megan Corporate Authors(s) : United States. Advisory Committee on Immunization Practices. COVID-19 Vaccines Work Group. Conference Author(s) : United States. Advisory Committee on Immunization Practices. Meeting (2022 February 4 : Atlanta, GA) Published Date : February 4, 2022 Series : ACIP meeting COVID-19 Vaccines URL : https://stacks.cdc.gov/view/cdc/114159 Wallace, Megan (2022). Grading of recommendations, assessment, development, and evaluation (GRADE) : Moderna COVID-19 vaccine. 202203(16). Wallace, Megan "Grading of recommendations, assessment, development, and evaluation (GRADE) : Moderna COVID-19 vaccine" 202203, no. 16 (2022) Wallace, Megan "Grading of recommendations, assessment, development, and evaluation (GRADE) : Moderna COVID-19 vaccine" vol. 202203, no. 16, 2022 Export RIS Citation Information. Copy Copied Save Generic APA MLA Chicago RIS [PDF - 580.91 KB] Personal Author: Wallace, Megan February 4, 2022 | ACIP meeting COVID-19 Vaccines Description: 06-COVID-Wallace-508.pdf File Type: [PDF - 580.91 KB] File Type: [PDF - 580.91 KB] Canadian experience and evidence with COVID-19 vaccine primary series extended intervals Cite CITE Title : Canadian experience and evidence with COVID-19 vaccine primary series extended intervals Personal Author(s) : Tunis, Matthew;Warshawsky, Byrna;Ogunnaike-Cooke, Susann; Corporate Authors(s) : Public Health Agency of Canada. Conference Author(s) : United States. Advisory Committee on Immunization Practices. Meeting (2022 February 4 : Atlanta, GA) Published Date : February 4, 2022 Series : ACIP meeting COVID-19 Vaccines URL : https://stacks.cdc.gov/view/cdc/114162 Tunis, Matthew et al. (2022). Canadian experience and evidence with COVID-19 vaccine primary series extended intervals. 202203(19). Tunis, Matthew and Warshawsky, Byrna and Ogunnaike-Cooke, Susann "Canadian experience and evidence with COVID-19 vaccine primary series extended intervals" 202203, no. 19 (2022) Tunis, Matthew et al. "Canadian experience and evidence with COVID-19 vaccine primary series extended intervals" vol. 202203, no. 19, 2022 Export RIS Citation Information. Copy Copied Save Generic APA MLA Chicago RIS [PDF - 897.54 KB] Personal Author: Tunis, Matthew ; Warshawsky, Byrna ... February 4, 2022 | ACIP meeting COVID-19 Vaccines Description: 09-COVID-Tunis-508.pdf File Type: [PDF - 897.54 KB] File Type: [PDF - 897.54 KB] Overview of BLA for use of Moderna’s COVID-19 vaccine (Spikevax) in individuals ≥18 years of age Cite CITE Title : Overview of BLA for use of Moderna’s COVID-19 vaccine (Spikevax) in individuals ≥18 years of age Personal Author(s) : Das, Rituparna Corporate Authors(s) : Moderna (firm) Conference Author(s) : United States. Advisory Committee on Immunization Practices. Meeting (2022 February 4 : Atlanta, GA) Published Date : February 4, 2022 Series : ACIP meeting COVID-19 Vaccines URL : https://stacks.cdc.gov/view/cdc/114155 Das, Rituparna (2022). Overview of BLA for use of Moderna’s COVID-19 vaccine (Spikevax) in individuals ≥18 years of age. 202203(12). Das, Rituparna "Overview of BLA for use of Moderna’s COVID-19 vaccine (Spikevax) in individuals ≥18 years of age" 202203, no. 12 (2022) Das, Rituparna "Overview of BLA for use of Moderna’s COVID-19 vaccine (Spikevax) in individuals ≥18 years of age" vol. 202203, no. 12, 2022 Export RIS Citation Information. Copy Copied Save Generic APA MLA Chicago RIS [PDF - 791.03 KB] Personal Author: Das, Rituparna February 4, 2022 | ACIP meeting COVID-19 Vaccines Description: 02-COVID-Das-508.pdf File Type: [PDF - 791.03 KB] File Type: [PDF - 791.03 KB] Myocarditis outcomes following mRNA COVID-19 vaccination : preliminary data : data are subject to change Cite CITE Title : Myocarditis outcomes following mRNA COVID-19 vaccination : preliminary data : data are subject to change Personal Author(s) : Kracalik, Ian Corporate Authors(s) : CDC COVID-19 Vaccine Planning Unit. Vaccine Safety Team. Conference Author(s) : United States. Advisory Committee on Immunization Practices. Meeting (2022 February 4 : Atlanta, GA) Published Date : February 4, 2022 Series : ACIP meeting COVID-19 Vaccines URL : https://stacks.cdc.gov/view/cdc/114157 Kracalik, Ian (2022). Myocarditis outcomes following mRNA COVID-19 vaccination : preliminary data : data are subject to change. 202203(14). Kracalik, Ian "Myocarditis outcomes following mRNA COVID-19 vaccination : preliminary data : data are subject to change" 202203, no. 14 (2022) Kracalik, Ian "Myocarditis outcomes following mRNA COVID-19 vaccination : preliminary data : data are subject to change" vol. 202203, no. 14, 2022 Export RIS Citation Information. Copy Copied Save Generic APA MLA Chicago RIS [PDF - 1.10 MB] Personal Author: Kracalik, Ian February 4, 2022 | ACIP meeting COVID-19 Vaccines Description: 04-COVID-Kracalic-508.pdf File Type: [PDF - 1.10 MB] File Type: [PDF - 1.10 MB] Evidence to recommendation framework : Moderna COVID-19 vaccine, Spikevax Cite CITE Title : Evidence to recommendation framework : Moderna COVID-19 vaccine, Spikevax Personal Author(s) : Oliver, Sara E. Corporate Authors(s) : United States. Advisory Committee on Immunization Practices. COVID-19 Vaccines Work Group. Conference Author(s) : United States. Advisory Committee on Immunization Practices. Meeting (2022 February 4 : Atlanta, GA) Published Date : February 4, 2022 Series : ACIP meeting COVID-19 Vaccines URL : https://stacks.cdc.gov/view/cdc/114160 Oliver, Sara E. (2022). Evidence to recommendation framework : Moderna COVID-19 vaccine, Spikevax. 202203(17). Oliver, Sara E. "Evidence to recommendation framework : Moderna COVID-19 vaccine, Spikevax" 202203, no. 17 (2022) Oliver, Sara E. "Evidence to recommendation framework : Moderna COVID-19 vaccine, Spikevax" vol. 202203, no. 17, 2022 Export RIS Citation Information. Copy Copied Save Generic APA MLA Chicago RIS [PDF - 6.00 MB] Personal Author: Oliver, Sara E. February 4, 2022 | ACIP meeting COVID-19 Vaccines Description: 07-COVID-Oliver-508.pdf File Type: [PDF - 6.00 MB] File Type: [PDF - 6.00 MB] Myocarditis and COVID-19 vaccine intervals : international data and policies Cite CITE Title : Myocarditis and COVID-19 vaccine intervals : international data and policies Personal Author(s) : Moulia, Danielle Corporate Authors(s) : United States. Advisory Committee on Immunization Practices. COVID-19 Vaccines Work Group. Conference Author(s) : United States. Advisory Committee on Immunization Practices. Meeting (2022 February 4 : Atlanta, GA) Published Date : February 4, 2022 Series : ACIP meeting COVID-19 Vaccines URL : https://stacks.cdc.gov/view/cdc/114164 Moulia, Danielle (2022). Myocarditis and COVID-19 vaccine intervals : international data and policies. 202203(11). Moulia, Danielle "Myocarditis and COVID-19 vaccine intervals : international data and policies" 202203, no. 11 (2022) Moulia, Danielle "Myocarditis and COVID-19 vaccine intervals : international data and policies" vol. 202203, no. 11, 2022 Export RIS Citation Information. Copy Copied Save Generic APA MLA Chicago RIS [PDF - 548.99 KB] Personal Author: Moulia, Danielle February 4, 2022 | ACIP meeting COVID-19 Vaccines Description: 11-COVID-Moulia-508.pdf File Type: [PDF - 548.99 KB] File Type: [PDF - 548.99 KB] Myocarditis analyses in the Vaccine Safety Datalink: rapid cycle analyses and “head-to-head” product comparisons Cite CITE Title : Myocarditis analyses in the Vaccine Safety Datalink: rapid cycle analyses and “head-to-head” product comparisons Personal Author(s) : Klein, Nicola P. Corporate Authors(s) : Kaiser Permanente Vaccine Study Center.;Marshfield Clinic Research Institute. Vaccine Safety Datalink. Immunization Safety Office.; Conference Author(s) : United States. Advisory Committee on Immunization Practices. Meeting (2022 February 4 : Atlanta, GA) Published Date : February 4, 2022 Series : ACIP meeting COVID-19 Vaccines URL : https://stacks.cdc.gov/view/cdc/114163 Klein, Nicola P. (2022). Myocarditis analyses in the Vaccine Safety Datalink: rapid cycle analyses and “head-to-head” product comparisons. 202203(10). Klein, Nicola P. "Myocarditis analyses in the Vaccine Safety Datalink: rapid cycle analyses and “head-to-head” product comparisons" 202203, no. 10 (2022) Klein, Nicola P. "Myocarditis analyses in the Vaccine Safety Datalink: rapid cycle analyses and “head-to-head” product comparisons" vol. 202203, no. 10, 2022 Export RIS Citation Information. Copy Copied Save Generic APA MLA Chicago RIS [PDF - 606.04 KB] Personal Author: Klein, Nicola P. February 4, 2022 | ACIP meeting COVID-19 Vaccines Description: 10-COVID-Klein-508.pdf File Type: [PDF - 606.04 KB] File Type: [PDF - 606.04 KB] Updates on myocarditis and pericarditis following Moderna COVID-19 vaccination Cite CITE Title : Updates on myocarditis and pericarditis following Moderna COVID-19 vaccination Personal Author(s) : Shimabukuro, Tom T. Corporate Authors(s) : CDC COVID-19 Vaccine Planning Unit. Vaccine Safety Team. Conference Author(s) : United States. Advisory Committee on Immunization Practices. Meeting (2022 February 4 : Atlanta, GA) Published Date : February 4, 2022 Series : ACIP meeting COVID-19 Vaccines URL : https://stacks.cdc.gov/view/cdc/114156 Shimabukuro, Tom T. (2022). Updates on myocarditis and pericarditis following Moderna COVID-19 vaccination. 202203(13). Shimabukuro, Tom T. "Updates on myocarditis and pericarditis following Moderna COVID-19 vaccination" 202203, no. 13 (2022) Shimabukuro, Tom T. "Updates on myocarditis and pericarditis following Moderna COVID-19 vaccination" vol. 202203, no. 13, 2022 Export RIS Citation Information. Copy Copied Save Generic APA MLA Chicago RIS [PDF - 756.09 KB] Personal Author: Shimabukuro, Tom T. February 4, 2022 | ACIP meeting COVID-19 Vaccines Description: 03-COVID-Shimabukuro-508.pdf File Type: [PDF - 756.09 KB] File Type: [PDF - 756.09 KB] Summary and Work Group interpretation : extended intervals for mRNA COVID-19 vaccines Cite CITE Title : Summary and Work Group interpretation : extended intervals for mRNA COVID-19 vaccines Personal Author(s) : Oliver, Sara E. Corporate Authors(s) : United States. Advisory Committee on Immunization Practices. COVID-19 Vaccines Work Group. Conference Author(s) : United States. Advisory Committee on Immunization Practices. Meeting (2022 February 4 : Atlanta, GA) Published Date : February 4, 2022 Series : ACIP meeting COVID-19 Vaccines URL : https://stacks.cdc.gov/view/cdc/114165 Oliver, Sara E. (2022). Summary and Work Group interpretation : extended intervals for mRNA COVID-19 vaccines. 202203(12). Oliver, Sara E. "Summary and Work Group interpretation : extended intervals for mRNA COVID-19 vaccines" 202203, no. 12 (2022) Oliver, Sara E. "Summary and Work Group interpretation : extended intervals for mRNA COVID-19 vaccines" vol. 202203, no. 12, 2022 Export RIS Citation Information. Copy Copied Save Generic APA MLA Chicago RIS [PDF - 1.50 MB] Personal Author: Oliver, Sara E. February 4, 2022 | ACIP meeting COVID-19 Vaccines Description: 12-COVID-Oliver-508.pdf File Type: [PDF - 1.50 MB] File Type: [PDF - 1.50 MB] ACIP COVID-19 Vaccines Work Group Cite CITE Title : ACIP COVID-19 Vaccines Work Group Personal Author(s) : Daley, Matthew F. Corporate Authors(s) : United States. Advisory Committee on Immunization Practices. COVID-19 Vaccines Work Group. Conference Author(s) : United States. Advisory Committee on Immunization Practices. Meeting (2022 February 4 : Atlanta, GA) Published Date : February 4, 2022 Series : ACIP meeting COVID-19 Vaccines URL : https://stacks.cdc.gov/view/cdc/114154 Daley, Matthew F. (2022). ACIP COVID-19 Vaccines Work Group. 202203(11). Daley, Matthew F. "ACIP COVID-19 Vaccines Work Group" 202203, no. 11 (2022) Daley, Matthew F. "ACIP COVID-19 Vaccines Work Group" vol. 202203, no. 11, 2022 Export RIS Citation Information. Copy Copied Save Generic APA MLA Chicago RIS [PDF - 1.03 MB] Personal Author: Daley, Matthew F. February 4, 2022 | ACIP meeting COVID-19 Vaccines Description: 01-COVID-Daley-508.pdf File Type: [PDF - 1.03 MB] File Type: [PDF - 1.03 MB] COVID-19 Vaccine Safety Technical (VaST) Work Group safety assessment Cite CITE Title : COVID-19 Vaccine Safety Technical (VaST) Work Group safety assessment Personal Author(s) : Talbot, H. Keipp;Hopkins, Robert H.; Corporate Authors(s) : United States. Advisory Committee on Immunization Practices. COVID-19 Vaccines Work Group. COVID-19 Vaccine Safety Technical (VaST) Subgroup. Conference Author(s) : United States. Advisory Committee on Immunization Practices. Meeting (2022 February 4 : Atlanta, GA) Published Date : February 4, 2022 Series : ACIP meeting COVID-19 Vaccines URL : https://stacks.cdc.gov/view/cdc/114158 Talbot, H. Keipp and Hopkins, Robert H. (2022). COVID-19 Vaccine Safety Technical (VaST) Work Group safety assessment. 202203(15). Talbot, H. Keipp and Hopkins, Robert H. "COVID-19 Vaccine Safety Technical (VaST) Work Group safety assessment" 202203, no. 15 (2022) Talbot, H. Keipp and Hopkins, Robert H. "COVID-19 Vaccine Safety Technical (VaST) Work Group safety assessment" vol. 202203, no. 15, 2022 Export RIS Citation Information. Copy Copied Save Generic APA MLA Chicago RIS [PDF - 306.66 KB] Personal Author: Talbot, H. Keipp ; Hopkins, Robert H. February 4, 2022 | ACIP meeting COVID-19 Vaccines Description: 05-COVID-Talbot-508.pdf File Type: [PDF - 306.66 KB] File Type: [PDF - 306.66 KB]

More +